Latest 10-Q quarterly reports

NYSE
Murphy USA Inc. announced robust financial performance for the first quarter of 2026, driven by increased fuel and merchandise contributions.
NYSE
Carriage Services reported a slight revenue decrease and a significant net income drop for the first quarter of 2026, impacted by prior year gains and increased administrative costs.
NASDAQ
Upwork Inc. reported a slight increase in Q1 2026 revenue to $195.5 million, while net income saw a decrease to $31.5 million compared to the prior year.
NASDAQ
Brighthouse Financial reported a net loss of $792 million for the first quarter of 2026, impacted by market volatility and derivative movements, while adjusted earnings showed a slight increase.
NASDAQ
Chord Energy Corporation announced its first quarter 2026 financial and operational results, highlighting increased revenues driven by higher commodity prices and production volumes, despite a significant unrealized loss on derivative contracts.
NASDAQ
Vertex, Inc. announced its first quarter 2026 financial results, showing an 11.1% increase in total revenues to $196.6 million, but a net loss of $2.5 million compared to a net income of $11.1 million in the prior year.
Chiron Real Estate Inc. reported a net income decrease for Q1 2026 compared to Q1 2025, alongside significant strategic acquisitions and a dividend modification.
NASDAQ
Perma-Fix Environmental Services reported a significant revenue decrease in Q1 2026 compared to the prior year, primarily due to lower waste volumes and strategic inventory management, while continuing to invest in PFAS technology.
NASDAQ
Xenon Pharmaceuticals Inc. reported strong Q1 2026 results, with positive Phase 3 data for azetukalner in focal onset seizures and significant capital raised, positioning the company for future growth.
NASDAQ
GCI Liberty reported a decrease in revenue for the first quarter of 2026, alongside significant strategic moves including an acquisition and a substantial investment in Liberty Latin America.
NYSE
Becton, Dickinson and Company (BD) reported its Q2 2026 financial results, detailing revenue growth and the impact of its recent spin-off of the Biosciences and Diagnostic Solutions business.
NYSE
Howmet Aerospace Inc. announced a significant increase in sales and net income for the first quarter of 2026, driven by strong performance in aerospace markets and strategic acquisitions.
NYSE
Hinge Health, Inc. announced a 47% year-over-year revenue increase for the first quarter of 2026, driven by strong client retention and member growth.
NASDAQ
Janux Therapeutics filed its Q1 2026 10-Q, detailing a net loss of $24.4 million and significant progress in its collaboration with Bristol-Myers Squibb.
NASDAQ
Vera Therapeutics reported a net loss of $121.0 million for Q1 2026, with significant increases in R&D and G&A expenses, while advancing its lead product candidate, atacicept, for IgAN.
NASDAQ
Green Plains Inc. reported a significant turnaround in its first quarter of 2026, achieving net income of $32.9 million and adjusted EBITDA of $71.5 million, largely due to substantial Section 45Z clean fuel production tax credits.
NASDAQ
Applied Optoelectronics reported a significant 51.4% revenue increase in Q1 2026, driven by strong data center demand, but also a wider net loss due to increased operating expenses and cost of goods sold.
NYSE
US Foods Holding Corp. announced its first quarter fiscal year 2026 results, showing a 2.8% increase in net sales to $9.61 billion, while net income remained stable at $116 million.
NASDAQ
PTC Therapeutics reported a significant increase in net product revenue for Q1 2026, driven by Sephience sales, while continuing to advance its diverse pipeline and manage operational expenses.
NYSE
Clearwater Analytics Holdings, Inc. reported a net loss for the first quarter of 2026, with revenue significantly increasing year-over-year, while navigating a pending acquisition.
NYSE
Wolfspeed, Inc. filed its Form 10-Q for the quarter ended March 29, 2026, detailing financial performance post-Chapter 11 emergence, with significant debt reduction and strategic facility adjustments.
NASDAQ
Aclaris Therapeutics reported increased revenue and a wider net loss in its Q1 2026 filing, with significant investment in R&D for its immuno-inflammatory disease pipeline.
NYSE
Globe Life Inc. announced a 6% increase in total premium and a 13% rise in health premium for the first quarter of 2026, with net income reaching $271 million.
NASDAQ
Beyond Meat's Q1 2026 filing reveals a 15.3% year-over-year revenue decrease to $58.2 million, alongside a narrowed net loss.
NASDAQ
Mercer International Inc. reported a net loss of $52.0 million for the first quarter of 2026, a significant increase from the prior year's loss, driven by lower pulp sales realizations and higher costs.
NASDAQ
IN8bio, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, reporting a net loss of $5.1 million and highlighting substantial doubt about its ability to continue as a going concern.
NASDAQ
BridgeBio Pharma's Q1 2026 results show significant revenue growth driven by product sales, alongside increased operating expenses and continued net losses.
NYSE
Redwood Trust Inc. reported a net loss of $5.5 million for the first quarter of 2026, impacted by market-driven valuation changes and restructuring expenses, despite record mortgage banking production.
NASDAQ
Ispire Technology Inc. reported a significant revenue decrease for the nine months ended March 31, 2026, alongside a reduction in net loss, driven by strategic shifts and operational adjustments.
NYSE
ESS Tech reported a significant 79% year-over-year revenue decline in Q1 2026, driven by the wind-down of existing contracts and a strategic pivot towards its Energy Base product.